Hildred Capital Partners Portfolio

Hildred Capital Partners Portfolio Summary

Hildred Capital Partners’ most common sector for investment islife science (100%). The Firm’s most common investment types include growth capital (67%) and divestiture (34%). In total, Hildred Capital Partners has invested in 2 US states and 2 different countries.

Sign-up to view Hildred Capital Partners’ full profile and discover more small family office investors just like it.

Portfolio Summary

  • Total Sectors Invested 1
  • Total Countries Invested 2

Hildred Capital Partners LLC

745 Fifth Avenue, Suite 1702,
New York, New York 10151
United States
(646) 362-5965
www.hildredpartners.com
office@hildredpartners.com

All (3) Current (2) Exited (1)
Status Dates Company Description
Investment    Exit       
Current 2018-11-30 - GlaxoSmithKline plc - Consumer Healthcare Portfolio
Life Science
Brentford, United Kingdom
GlaxoSmithKline plc - Consumer Healthcare Portfolio has long been regarded as high quality, safe and effective, maintaining a quality image and loyal base of consumers. OTC medications allow practitioners and their patients the ability to access therapeutic products while reducing the burden of prescription drug costs on the healthcare system. The products expand Crown Laboratories’ consumer portfolio by adding #1 in category brands that treat multiple conditions. The acquired portfolio includes PanOxyl®: #1 Dermatologist recommended daily acne wash Sarna®: #1 Dermatology recommended anti-itch lotion Zeasorb®: #1 Dermatologist recommended anti-fungal and prevention product Desenex®: Anti-fungal powder for athlete’s foot Mineral Ice®: Leading pain-relieving gel.

Acquired From Val
GSK -

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.